Papers - ISHIKAWA, Tetsuya
-
Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection. Reviewed
Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M, Yoshioka K.
Clin Exp Immunol Vol. 108 ( 1 ) page： 138-143 1997.4
-
Humoral immune response to the hypervariable region of hepatitis C virus differs between genotype 1b and 2a. Reviewed
Yoshioka K, Aiyama T, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Nagai Y, Kakumu S.
J Infect Dis Vol. 175 ( 3 ) page： 505-510 1997.3
-
Cyclosporine therapy affects amino-transferase activity but not hepatitis C virus RNA levels in chronic hepatitis C. Reviewed
Kakumu S, Takayanagi M, Iwata K, Okumura A, Aiyama T, Ishikawa T, Nadai M, Yoshioka K.
J Gastroenterol Hepatol Vol. 12 ( 1 ) page： 62-66 1997.1
-
Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome. Reviewed
Aiyama T, Yoshioka K, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Kakumu S.
Hepatology Vol. 24 ( 6 ) page： 1346-1350 1996.12
-
Sequence analysis of hypervariable region of hepatitis C virus (HCV) associated with immune complex in patients with chronic HCV infection. Reviewed
Aiyama T, Yoshioka K, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Kakumu S.
J Infect Dis Vol. 174 ( 6 ) page： 1316-1320 1996.12
-
Serial analysis of hepatitis B virus core nucleotide sequence of patients with acute exacerbation during chronic infection. Reviewed
Okumura A, Takayanagi M, Aiyama T, Iwata K, Wakita T, Ishikawa T, Yoshioka K, Kakumu S.
J Med Virol Vol. 49 ( 2 ) page： 103-109 1996.6
-
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Reviewed
Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber RD, Chisari FV.
Immunity Vol. 4 ( 1 ) page： 25-36 1996.1
-
Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Reviewed
Tsui LV, Guidotti LG, Ishikawa T, Chisari FV.
Proc Natl Acad Sci USA Vol. 92 ( 26 ) page： 12398-12402 1995.12
-
CTL access to tissue antigen is restricted in vivo. Reviewed
Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV.
J Immunol Vol. 153 ( 2 ) page： 482-488 1994.7
-
ClassⅠrestricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. Reviewed
Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, Schreiber RD, Schricht HJ, Huang S, Chisari FV.
J Immunol Vol. 152 ( 7 ) page： 3245-3253 1994.4
-
Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Reviewed
Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel RD, Schreiber RD, Chisari FV.
Proc Natl Acad Sci USA Vol. 91 ( 9 ) page： 3764-3768 1994.4
-
Hepatitis C virus genotypes are not responsible for development of serious liver disease. Reviewed
Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanagi M.
Dig Dis Sci Vol. 39 ( 2 ) page： 234-239 1994.2
-
Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B. Reviewed
Kakumu S, Ishikawa T, Wakita T, Yoshioka K, Takayanagi M, Tahara H, Kusakabe A.
Am J Gastroenterol Vol. 89 ( 1 ) page： 92-96 1994.1
-
Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Reviewed
Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y.
Virology Vol. 197 ( 2 ) page： 659-668 1993.12
-
Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B. Reviewed
Ito Y, Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Koike K.
J Gastroenterol Vol. 28 ( 5 ) page： 657-665 1993.10
-
Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T cell response. Reviewed
Ishikawa T, Kakumu S, Yoshioka K, Yamada Y, Tanaka K, Higashi Y, Takayanagi M, Okumura A, Kojima A, Tamura S.
Immunology Vol. 80 ( 2 ) page： 313-318 1993.10
-
Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection. Reviewed
Takayanagi M, Kakumu S, Wakita T, Ishikawa T, Yoshioka Y, Higashi Y.
Virology Vol. 196 ( 1 ) page： 138-145 1993.9
-
A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Reviewed
Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y.
Gastroenterology Vol. 105 ( 2 ) page： 507-512 1993.8
-
Pilot study of ribavirin and interferon-beta for chronic hepatitis B. Reviewed
Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y.
Hepatology Vol. 18 ( 2 ) page： 258-263 1993.8
-
Effects of interferon-alpha treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B. Reviewed
Ishikawa T, Kakumu S, Yoshioka K, Kurokawa S, Kusakabe A, Tahara H, Hirofuji H, Kawabe M.
Liver Vol. 13 ( 2 ) page： 95-101 1993.4